1. Home
  2. MBBC vs IXHL Comparison

MBBC vs IXHL Comparison

Compare MBBC & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marathon Bancorp Inc.

MBBC

Marathon Bancorp Inc.

HOLD

Current Price

$14.67

Market Cap

44.1M

Sector

Finance

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$2.68

Market Cap

35.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBBC
IXHL
Founded
1902
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
44.1M
35.4M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
MBBC
IXHL
Price
$14.67
$2.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2K
★ 54.3K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 3200.00
N/A
EPS
★ 0.66
N/A
Revenue
N/A
★ $12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.97
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.53
$0.16
52 Week High
$15.79
$6.39

Technical Indicators

Market Signals
Indicator
MBBC
IXHL
Relative Strength Index (RSI) 37.43 29.84
Support Level $14.16 $2.49
Resistance Level $15.39 $3.89
Average True Range (ATR) 0.14 0.13
MACD -0.06 -0.04
Stochastic Oscillator 36.13 14.00

Price Performance

Historical Comparison
MBBC
IXHL

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.

Share on Social Networks: